Prosensa and GSK add to muscular dystrophy alliance
June 23, 2010Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy
GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …
Mixed reaction for Osborne’s first Budget
June 23, 2010Research and Development, Sales and Marketing biotech, pharma, tax, tax relief
George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
Congress summons J&J chief executive
June 23, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …
PRA bolsters late phase services
June 23, 2010Research and Development CRO, PRA, appointment, research and development
Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …
Sanofi signs microRNA therapy deal
June 23, 2010Research and Development RNA, Regulus, Sanofi-Aventis
Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …
Medical Affairs at the Centre of Life Sciences Innovation
June 22, 2010Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Europe must move on from ‘simplistic’ pricing
June 22, 2010Research and Development Europe, hta, pricing, pricing & Reimbursement
GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
Pfizer withdraws blood cancer drug in US
June 22, 2010Sales and Marketing AML, Mylotarg, Pfizer, blood cancer
The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …
NHS targets and management costs in the firing line
June 22, 2010NHS, NHS funding, NHS targets
Management costs and the use of targets are at the top of the government’s NHS hitlist, the health secretary Andrew Lansley has …
FDA tightens pharma’s responsibility for outsourcing
June 22, 2010Manufacturing and Production FDA, GMP, manufacturing, outsourcing
Pharmaceutical manufacturers will be held more responsible for the activities of their suppliers and outsourcing partners under a new approach …
Manufacturing news in brief
June 22, 2010Manufacturing and Production Almac, CPL Biologicals, KV Pharma, KV Pharmaceutical, NerPharMa, ProBioGen
German contract manufacturer ProBioGen is bought by Egypt’s Minapharm, plus there are facility updates from NerPharMa DS, CPL Biologicals and …
NDA appoints Dr Panos Tsintis
June 22, 2010Sales and Marketing NDA, appointment, sales and marketing
European regulatory affairs consulting group NDA has appointed Dr Panos Tsintis medical advisor to NDA Regulatory Science in a move …
Dr Geoffrey Nichol joins Ikaria
June 22, 2010Research and Development Ikaria, appointment, research and development
US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
Working Life: Jo Ferdinando
June 22, 2010Manufacturing and Production, Research and Development Shire, Working Life, careers
How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …
Let’s avoid further stand-offs, says Witty
June 22, 2010Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing
Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
Digital Pharma: Online trial safety reporting
June 21, 2010Research and Development FDA, MHRA, digital research, drug safety
From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …
Bayer launches world’s first cannabis-derived prescription drug
June 21, 2010Sales and Marketing Bayer, GW Pharmaceuticals, Sativex
Bayer Healthcare has launched the world’s first cannabis-derived prescription drug in the UK. Sativex treats the spasticity symptoms of multiple …
GSK tops access to medicines ranking
June 21, 2010Sales and Marketing GlaxoSmithKline, developing world, medicines access
GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …
Tasigna more effective than Glivec, says Novartis
June 21, 2010Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia
Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …
Depomed pulls diabetes drug Glumetza
June 21, 2010Manufacturing and Production Depomed, Glumetza, manufacturing compliance
Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
